mibefradil has been researched along with dihydropyridines in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 17 (73.91) | 29.6817 |
2010's | 1 (4.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hofmann, F; Schuster, A; Seisenberger, C; Welling, A | 1 |
Nakagawa, M; Sasaki, S | 1 |
Conlin, PR; Williams, GH | 1 |
Allen, TJ; Cao, Z; Cooper, ME; Hulthén, UL | 1 |
Horowitz, BZ; Linden, DH; Mullins, ME; Norton, RL; Smith, GW; Stump, J | 1 |
Hofmann, F; Klugbauer, N; Lacinová, L | 1 |
Antepohl, W; Haaf, O; Herzig, S; Huber, I; Matthes, J; Striessnig, J | 1 |
Protas, L; Robinson, RB | 1 |
Budihna, MV; Drevensek, G; Martinuc, J | 1 |
Arh, M; Budihna, MV | 1 |
Andreasen, D; Gustafsson, F; Holstein-Rathlou, N; Jensen, BL; Salomonsson, M | 1 |
Bakris, GL; Bidani, AK; Griffin, KA; Picken, M | 1 |
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Tokuyama, H | 1 |
Hayashi, K; Honda, M; Kubota, E; Matsuda, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tokuyama, H | 1 |
Kim, YC; Koh, SD; Sanders, KM | 1 |
Shigenobu, K; Tanaka, H | 1 |
Hadama, T; Kaku, T; Lee, TS; Miyamoto, S; Ono, K; Perez-Reyes, E; Takebayashi, S; Uchino, T | 1 |
Akaike, N; Kim, CJ; Min, BI; Ogawa, S; Shin, MC; Tanaka, E | 1 |
Perez-Reyes, E; Van Deusen, AL; Vitko, I | 1 |
Ball, CJ; Beltrame, JF; Saint, DA; Turner, SP; Wilson, DP | 1 |
Godfraind, T | 1 |
Arai, Y; Fujiwara, M; Harada, M; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Murakami, M; Nakagawa, Y; Nakanishi, M; Nakao, K; Takano, M; Ueshima, K; Yasuno, S | 1 |
Huang, CS; Kuo, CC; Pan, MK; Tai, CH; Yang, YC | 1 |
3 review(s) available for mibefradil and dihydropyridines
Article | Year |
---|---|
[Calcium channel blocker for therapy of patients with hypertension].
Topics: Benzimidazoles; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes; Thiazoles | 1997 |
Use of calcium channel blockers in hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Case-Control Studies; Clinical Trials as Topic; Dihydropyridines; Diltiazem; Heart Diseases; Humans; Hypertension; Longitudinal Studies; Mibefradil; Nifedipine; Public Health; Randomized Controlled Trials as Topic; Risk Factors; Tetrahydronaphthalenes; Vasodilator Agents; Verapamil | 1998 |
Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Drug Design; Humans; Mibefradil; Nitrophenols; Organophosphorus Compounds | 2005 |
20 other study(ies) available for mibefradil and dihydropyridines
Article | Year |
---|---|
Two stable cell lines for screening of calcium channel blockers.
Topics: Benzimidazoles; Calcium Channel Blockers; Cell Line; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fura-2; Heart; Mibefradil; Muscle, Smooth, Vascular; Myocardium; Nisoldipine; Patch-Clamp Techniques; Polymerase Chain Reaction; Potassium; Structure-Activity Relationship; Tetrahydronaphthalenes; Transfection | 1995 |
Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Dihydropyridines; Hypertrophy; Male; Mesenteric Arteries; Mibefradil; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Ramipril; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes | 1998 |
Life-threatening interaction of mibefradil and beta-blockers with dihydropyridine calcium channel blockers.
Topics: Adrenergic beta-Antagonists; Aged; Benzimidazoles; Calcium Channel Blockers; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dihydropyridines; Drug Interactions; Female; Half-Life; Humans; Mibefradil; Mixed Function Oxygenases; Shock, Cardiogenic; Sinoatrial Node; Tetrahydronaphthalenes | 1998 |
Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers.
Topics: Cadmium; Calcium Channel Blockers; Calcium Channels, T-Type; Cations; Cell Line; Dihydropyridines; Electrophysiology; Humans; Kidney; Mibefradil; Nickel; Patch-Clamp Techniques; Transfection | 2000 |
Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
Topics: Amlodipine; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Cell Membrane; Dihydropyridines; Drug Interactions; Ethosuximide; Female; Gallopamil; Humans; In Vitro Techniques; Isradipine; Male; Mibefradil; Myocardial Contraction; Perfusion; Radioligand Assay; Rats; Rats, Wistar; Ventricular Pressure | 2000 |
Mibefradil, an I(Ca,T) blocker, effectively blocks I(Ca,L) in rabbit sinus node cells.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Female; Mibefradil; Nifedipine; Rabbits; Sinoatrial Node | 2000 |
Action of mibefradil and lacidipine on the isolated human anterior tibial artery.
Topics: Calcium Channel Blockers; Dihydropyridines; Humans; In Vitro Techniques; Mibefradil; Osmolar Concentration; Potassium Chloride; Tibial Arteries; Vasoconstriction; Vasoconstrictor Agents | 2000 |
Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Mibefradil; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrendipine; Pressure; Rats; Rats, Wistar; Reference Values; Ventricular Function, Left | 2000 |
Conducted vasoconstriction in rat mesenteric arterioles: role for dihydropyridine-insensitive Ca(2+) channels.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Electric Stimulation; Enzyme Inhibitors; Gene Expression; Male; Mesenteric Arteries; Mibefradil; NG-Nitroarginine Methyl Ester; Nickel; Norepinephrine; Phentolamine; Potassium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrodotoxin; Vasoconstriction | 2001 |
Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Homeostasis; Kidney; Male; Mibefradil; Models, Biological; Rats; Rats, Sprague-Dawley | 2001 |
Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Male; Mibefradil; Natriuresis; Nifedipine; Nitric Oxide; Nitrophenols; Organophosphorus Compounds; Prostaglandins; Renal Circulation | 2001 |
Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Dogs; Hemodynamics; Mibefradil; Microcirculation; Nifedipine; Nitrophenols; Organophosphorus Compounds; Renal Circulation; Vasodilation | 2001 |
Voltage-dependent inward currents of interstitial cells of Cajal from murine colon and small intestine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cells, Cultured; Colon; Dihydropyridines; Electrophysiology; In Vitro Techniques; Intestine, Small; Ion Channel Gating; Membrane Potentials; Mibefradil; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Muscle, Smooth; Nickel; Patch-Clamp Techniques; Sodium | 2002 |
Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Topics: Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Humans; Mibefradil; Nifedipine; Nitrophenols; Organophosphorus Compounds; Recombinant Proteins | 2006 |
A selective T-type Ca2+ channel blocker R(-) efonidipine.
Topics: Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, T-Type; Dihydropyridines; Dose-Response Relationship, Drug; Flunarizine; Mibefradil; Nitrophenols; Nystatin; Organophosphorus Compounds; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Pyramidal Cells; Rats; Rats, Wistar; Sodium Channels | 2008 |
Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Calcium Channels, T-Type; Cells, Cultured; Dihydropyridines; Humans; Mibefradil; Nitrophenols; Organophosphorus Compounds; Verapamil | 2009 |
Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
Topics: Animals; Aorta; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Humans; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Mibefradil; Microvessels; Nifedipine; Nitrophenols; Organophosphorus Compounds; Potassium Chloride; Rats; Rats, Sprague-Dawley; Subcutaneous Fat; Vasoconstriction; Verapamil | 2009 |
Is combined L- and T-channel blockade better than L-channel blockade in therapy?
Topics: Animals; Aorta; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dihydropyridines; Drug Synergism; Humans; Hypertension; Mesenteric Arteries; Mibefradil; Microvessels; Nifedipine; Nitrophenols; Rats; Vasoconstriction; Verapamil | 2009 |
T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Dihydropyridines; Disease Models, Animal; Female; Mibefradil; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarction; Myocytes, Cardiac; Nitrendipine; Nitrophenols; Organophosphorus Compounds; Patch-Clamp Techniques | 2009 |
Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.
Topics: Animals; Benzimidazoles; Cadmium; Calcium; Calcium Channels, T-Type; Cyclopropanes; Dihydropyridines; Disease Models, Animal; Electrophysiology; Male; Mibefradil; Movement; Naphthalenes; Neurons; Nickel; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Rats; Rats, Wistar | 2011 |